Volume Alert - ACT 261.24 Actavis Inc $ACT Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 11:29 AM

Volume Alert - ACT 261.24 Actavis Inc $ACT Hit a high today of 264.00 Closing the day 10:30 at 261.24 +13.30 +5.36% With a day low of 249.86 and a total volume of 4,598,087.

ACT Recent Posts: http://investorshangout.com/Actavis-Inc-ACT-53105/

ACT Actavis Inc Recent Headline News

Actavis (ACT) Is Today's Unusual Social Activity Stock
at The Street - 14 mins ago
Trade-Ideas LLC identified Actavis (ACT) as an unusual social activity candidate
ACT: 260.23 (+12.29)

One Factor Driving Up Actavis (ACT) Stock Today
at The Street - 22 mins ago
Actavis (ACT) shares continue to climb as analysts at Citigroup (C) raised the company's price target following its purchase of Allergan (AGN) for $66 billion.
ACT: 260.33 (+12.39)

Stock Market News for November 18, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 1 hr 18 mins ago
Markets ended its choppy run yesterday on a mixed note after Japan unexpectedly slipped into a recession
AGN: 212.10 (+2.90), ACT: 260.33 (+12.39), EOG: 97.17 (+0.82), HAL: 49.59 (+0.36), HP: 77.44 (-0.81), MRO: 31.90 (+0.08), BHI: 65.76 (+0.53)

Will Pfizer's Dividend Be Safe?
Todd Campbell, The Motley Fool - Motley Fool - 1 hr 59 mins ago
Source: Pfizer via Facebook. Pfizer (NYSE: PFE) may be one of the planet's largest drugmakers, but it's been navigating a series of sales-crunching patent expirations that has investors wondering if the company's dividend payout will remain...
ACT: 260.33 (+12.39), PFE: 30.57 (+0.25), TEVA: 57.44 (+0.20)

Winners And Losers In The Allergan Valeant Actavis Melee; Also, Will Bill Ackman Lose His Profit?
Uncommon Profit Investor - at Seeking Alpha - 2 hrs 55 mins ago

AGN: 212.00 (+2.80), VRX: 141.24 (+4.51), ACT: 260.33 (+12.39)

Here Are Some Big Caps Poised To Make Gains
at Investor's Business Daily - Mon Nov 17, 5:45PM CST
Several Big Cap 20 stocks have recently broken out of bases, but are still within buy range, or are building new bases and could be good additions to a watch list. Alexion Pharmaceuticals (ALXN) has pulled back and is within the 5% buy zone. The...
AGN: 212.00 (+2.80), ACT: 260.33 (+12.39), VRX: 141.24 (+4.51), V: 250.52 (+0.72), ALXN: 190.26 (+3.48), CTSH: 52.76 (-0.30), MA: 83.66 (+0.46), ADS: 282.56 (+1.68)

Bristol-Myers Squibb Reports Positive Opdivo Phase III Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:20PM CST
Bristol-Myers Squibb Company announced encouraging data from the phase III CheckMate - 066 study on immuno-oncology drug Opdivo.
AGN: 212.00 (+2.80), ACT: 260.33 (+12.39), AMAG: 36.27 (+1.51), BMY: 58.69 (+0.26)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 4:40PM CST

URBN: 27.99 (-2.84), DHX: 11.32 (+0.06), ACT: 260.33 (+12.39), OME: 12.43 (-2.55), CLVS: 53.47 (+0.14), AVB: 158.37 (+0.21), PF: 32.42 (-1.30), RMTI: 10.31 (-0.27), GLW: 20.45 (+0.09), FOLD: 6.33 (-0.37)

Actavis to spend $66 billion on Allergan
By TOM MURPHY - AP - Mon Nov 17, 4:01PM CST
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
1 Comment
DRTX: 24.16 (+0.41), AGN: 212.00 (+2.80), ACT: 260.33 (+12.39), VRX: 141.24 (+4.51), MRK: 59.86 (+0.40), VRX.TO: 159.70 (+5.30)

Stocks End Mixed As Allergan Jumps On Actavis Deal
at Investor's Business Daily - Mon Nov 17, 3:16PM CST
Major averages pared losses from a late-morning slump to end mixed amid big merger deals and weak economic data. The S&P 500 and Dow Jones industrial average closed fractionally higher, while the Nasdaq fell 0.4%. Volume ran lower across the board in...
AGN: 212.00 (+2.80), VRX: 141.24 (+4.51), ACT: 260.33 (+12.39), SAFM: 86.42 (+1.49), PPC: 31.21 (+0.27), MIK: 21.99 (+0.34), TSN: 42.31 (-0.72)

Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge
at The Street - Mon Nov 17, 3:15PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies momentarily distracts Wall Street from worrying news Japan has fallen into recession in its third quarter.
AMZN: 327.57 (+4.52), HAS: 55.97 (-0.40), ACT: 260.33 (+12.39), VRX: 141.24 (+4.51), JIVE: 6.41 (+0.04), FB: 74.37 (+0.13), HAL: 49.60 (+0.37), DWA: 22.18 (-0.13), AGN: 212.00 (+2.80), LNKD: 224.68 (+1.40), BHI: 65.75 (+0.52), CRM: 63.02 (+0.51)

Stocks Mixed In Afternoon; Allergan Jumps To New High
at Investor's Business Daily - Mon Nov 17, 2:13PM CST
Stocks remained mixed late Monday afternoon as investors weighed a spate of merger activity against news that Japan fell into a recession. The Dow Jones industrial average and the S&P 500 were each up 0.1%, while the Nasdaq was down 0.3%. Volume was...
AGN: 212.00 (+2.80), VRX: 141.24 (+4.51), ACT: 260.33 (+12.39), LNKD: 224.68 (+1.40), FB: 74.37 (+0.13), HAL: 49.60 (+0.37), BHI: 65.75 (+0.52), Z: 117.43 (-0.43)

Stock Market Today: Stocks Are Mixed as Corporate Deals Offset Japan's Recession
at The Street - Mon Nov 17, 12:16PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies distract Wall Street from worrying news Japan had fallen into recession in its third quarter.
AGN: 212.00 (+2.80), HAS: 55.97 (-0.40), AMZN: 327.57 (+4.52), VRX: 141.24 (+4.51), ACT: 260.33 (+12.39), LNKD: 224.68 (+1.40), JIVE: 6.41 (+0.04), FB: 74.36 (+0.12), HAL: 49.60 (+0.37), DWA: 22.18 (-0.13), CRM: 63.02 (+0.51), BHI: 65.75 (+0.52)

Pershing Square wins big on Actavis buy
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:22AM CST

AGN: 212.00 (+2.80), ACT: 260.33 (+12.39), VRX: 141.24 (+4.51)

Cramer: Investors Should Ignore Analysts' Calls on Hotel, Other Stocks
at The Street - Mon Nov 17, 10:32AM CST
Analysts have been growing pessimistic on several high quality stocks and sectors. Investors should use weakness as a buying opportunity instead, Cramer said.
AGN: 212.00 (+2.80), ACT: 260.33 (+12.39), PG: 87.96 (+0.12), MAR: 76.71 (-0.46), HOT: 77.41 (+0.56)

Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman
at The Street - Mon Nov 17, 9:59AM CST
Valeant says it can't justify $219 a share offer to shareholders.
ZTS: 43.65 (-0.58), AGN: 212.00 (+2.80), VRX: 141.24 (+4.51), ACT: 260.33 (+12.39)

Stock Market Today: Stocks Shrug Off Japan's Recession as Deals Dominate Day
at The Street - Mon Nov 17, 9:40AM CST
U.S. stocks recover from earlier lows triggered by Japan's recession. Deals news about Baker Hughes and Allergan dominate headlines.
AGN: 212.00 (+2.80), HAS: 55.97 (-0.40), ACT: 260.33 (+12.39), HAL: 49.60 (+0.37), DWA: 22.18 (-0.13), BHI: 65.75 (+0.52)

ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Mon Nov 17, 9:32AM CST
Rigrodsky & Long, P.A.:
AGN: 212.00 (+2.80), ACT: 260.33 (+12.39)

Actavis Nabs Allergan For $66 Billion; Valeant Folds
at Investor's Business Daily - Mon Nov 17, 9:17AM CST
One of the most widely rumored deals in pharma came to fruition Monday, as Actavis (ACT) agreed to acquire Allergan (AGN) for $66 billion in cash and stock. Allergan stock was up more than 7%, near 213, and Actavis stock up nearly 4%, near 253, in...
AGN: 212.00 (+2.80), VRX: 141.24 (+4.51), ACT: 260.33 (+12.39)

Time to move on: Valeant chief says $219 too rich
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:13AM CST

ACT: 260.33 (+12.39), VRX: 141.24 (+4.51)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VitalCore Pioneers Jail Behavioral Health Expansion

The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...

Everpure Surges into the S&P 500: A Milestone Move

Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...

Job Market Shifts: Adaptation vs. Fairness Dilemma

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

RARE Foundation Rebrands, Focus Still Strong

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Facility Solutions Group Climbs to Top 18 Electrical Spot

FSG Shines Brightly in Electrical Contractor Rankings Climbing the ladder is no easy feat, but Facility Solutions Group (FSG) has managed to climb, all the way to the #18 spot on Electrical Construction & Maintenance (EC&M) magazine's revered list of the Top Electrical Contractors in the U.S. It’s up from their previous rank of 22. When you think about the competitive...

Agroz's Big Leap: New Supply Deal in Malaysia

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

ZEEKR's Shooting Brakes Dominate: Over 400K Sold

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Webinar Highlights Workforce Skills and AI Tools

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

The Austin Company to Showcase at ISPE Annual Event

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...